Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:189-192
Published online before print January 6, 2005, doi: 10.1161/01.STR.0000153069.96296.fd
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/2/189    most recent
01.STR.0000153069.96296.fdv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo, E. H.
Right arrow Articles by Jacobs, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, E. H.
Right arrow Articles by Jacobs, T. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Apoptosis

(Stroke. 2005;36:189.)
© 2005 American Heart Association, Inc.


Advances in Stroke 2004

Exciting, Radical, Suicidal

How Brain Cells Die After Stroke

Eng H. Lo, PhD; Michael A. Moskowitz, MD Thomas P. Jacobs, PhD

From the Neuroprotection Research Laboratory (E.H.L.), Departments of Radiology and Neurology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Charlestown, Mass; the Neurovascular Regulation and Stroke Laboratory (M.A.M.), Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass; and the Neural Environment Cluster (T.P.J.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.

Correspondence to Dr Eng H. Lo, Neuroprotection Research Laboratory, Harvard Medical School, MGH East 149-2401, Charlestown, MA 02129. E-mail Lo@helix.mgh.harvard.edu


Key Words: Advances in Stroke • apoptosis • erythopoietin • ischemia • neuroprotective agents


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
It is now widely accepted that not all brain cells die immediately after stroke. Surrounding a core of severe and rapid tissue injury, brain cell death evolves more slowly in a heterogeneous area that has been called the penumbra.1,2 In 1977, Astrup et al provided one of the first experimental demonstrations of the penumbra in a baboon model of cerebral artery occlusion.3 This region of brain in acute ischemic stroke was found to be electrically silent but sufficiently active metabolically to sustain membrane potentials. Neurons within the penumbra are functionally impaired but not yet dead. Without reperfusion, the penumbra collapses, brain cells die, and the lesion expands.

Although the precise timing and cellular pathways involved are not fully understood, it is believed that mechanisms actively promoting cell death are triggered after stroke. Remarkable progress has been made in dissecting these mechanisms over the past 3 decades. Three major pathways have emerged: excitotoxicity, oxidative stress, and apoptosis, and they are inextricably linked. Here, we explore the notion that stroke is most fruitfully investigated by an integrative "systems biology" approach that encompasses cell death and survival signaling within all components of the neurovascular unit.


*    Cell Death: A Convergence of Factors
 
How do brain cells die after stroke? A large body of data suggest that it may be exciting (glutamate and excitotoxicity), radical (oxidative stress and free radicals), and suicidal (apoptotic-like pathways).4–6 Simply put, when brain fails to generate sufficient ATP, such as after oxygen and glucose deprivation, energy failure occurs and ionic gradients are lost. Glutamate is released, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. O. Breckwoldt, J. W. Chen, L. Stangenberg, E. Aikawa, E. Rodriguez, S. Qiu, M. A. Moskowitz, and R. Weissleder
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase
PNAS, November 25, 2008; 105(47): 18584 - 18589.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Bull, J. P. Finkelstein, J. Galvez, G. Sanchez, P. Donoso, M. I. Behrens, and C. Hidalgo
Ischemia Enhances Activation by Ca2+ and Redox Modification of Ryanodine Receptor Channels from Rat Brain Cortex
J. Neurosci., September 17, 2008; 28(38): 9463 - 9472.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Jin, K. Arai, Y. Murata, S. Wang, M. F. Stins, E. H. Lo, and K. van Leyen
Protecting Against Cerebrovascular Injury: Contributions of 12/15-Lipoxygenase to Edema Formation After Transient Focal Ischemia
Stroke, September 1, 2008; 39(9): 2538 - 2543.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. L. Sacchetti
Is It Time to Definitely Abandon Neuroprotection in Acute Ischemic Stroke?
Stroke, June 1, 2008; 39(6): 1659 - 1660.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Guo, W. J. Kim, J. Lok, S.-R. Lee, E. Besancon, B.-H. Luo, M. F. Stins, X. Wang, S. Dedhar, and E. H. Lo
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
PNAS, May 27, 2008; 105(21): 7582 - 7587.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Sun, H. H. Marti, and R. Veltkamp
Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1{alpha} Expression in Focal Cerebral Ischemia
Stroke, March 1, 2008; 39(3): 1000 - 1006.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. N. Nagaraja, K. Karki, J. R. Ewing, R. L. Croxen, and R. A. Knight
Identification of Variations in Blood-Brain Barrier Opening After Cerebral Ischemia by Dual Contrast-Enhanced Magnetic Resonance Imaging and T1sat Measurements
Stroke, February 1, 2008; 39(2): 427 - 432.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Chu, S.-T. Lee, D.-I. Sinn, S.-Y. Ko, E.-H. Kim, J.-M. Kim, S.-J. Kim, D.-K. Park, K.-H. Jung, E.-C. Song, et al.
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation
Stroke, January 1, 2007; 38(1): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. van Leyen, H. Y. Kim, S.-R. Lee, G. Jin, K. Arai, and E. H. Lo
Baicalein and 12/15-Lipoxygenase in the Ischemic Brain
Stroke, December 1, 2006; 37(12): 3014 - 3018.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
O. Wu, S. Christensen, N. Hjort, R. M. Dijkhuizen, T. Kucinski, J. Fiehler, G. Thomalla, J. Rother, and L. Ostergaard
Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI
Brain, September 1, 2006; 129(9): 2384 - 2393.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. B. Tatro
Melanocortins Defend their Territory: Multifaceted Neuroprotection in Cerebral Ischemia.
Endocrinology, March 1, 2006; 147(3): 1122 - 1125.
[Full Text] [PDF]